21:08:02 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



CYTR INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving CytRx Corporation and a Lead Plaintiff Deadline of September 23, 2016

2016-08-31 10:16 ET - News Release

NEW YORK, Aug. 31, 2016 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who purchased CytRx Corporation (NASDAQ: CYTR) securities between November 18, 2014 and July 11, 2016.

The Law Offices of Vincent Wong logo (PRNewsFoto/The Law Offices of Vincent Wong)

Click here to learn about the case: http://www.wongesq.com/pslra/cytrx-corporation. There is no cost or obligation to you.

According to the complaint, throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose material adverse facts including: (1) that the clinical hold placed on the Phase 3 trial of aldoxorubicin for soft tissue sarcomas ("STSs") would prevent sufficient follow-up for patients involved in the study; (2) that, as a result, nearly half of all patients would be excluded from the data since the study was disturbed by a partial clinical hold; (3) that, in response, CytRx would likely conduct a second analysis; (4) that, as such, the results of the trial could be materially affected and/or approval of aldoxorubicin for STS could be delayed; and (5) that, as a result of the foregoing, Defendants' statements about CytRx's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

If you suffered a loss in CytRx you have until September 23, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/cytrx-corporation.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights.  Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: 
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

Logo - http://photos.prnewswire.com/prnh/20140904/143045

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cytr-investor-alert-the-law-offices-of-vincent-wong-notifies-investors-of-a-class-action-involving-cytrx-corporation-and-a-lead-plaintiff-deadline-of-september-23-2016-300320726.html

SOURCE The Law Offices of Vincent Wong

© 2024 Canjex Publishing Ltd. All rights reserved.